COPD and Asthma

Asthma: New Insights & Therapies highlights the latest developments in the understanding and treatment of asthma, focusing on innovative therapies and evolving clinical practices. It will explore advances in the pathophysiology of asthma, including the role of inflammation and immune responses, along with breakthroughs in biologics and targeted treatments. Discussions will cover early diagnosis, personalized treatment plans, and strategies to improve disease control and patient adherence. Experts will also address environmental triggers, prevention methods, and emerging technologies in asthma care. This session aims to provide participants with updated knowledge and practical approaches to enhance asthma management and patient outcomes.

• Advances in Asthma Pathophysiology
• Biologic Therapies & Targeted Treatments
• Pediatric & Geriatric Asthma Care
• Asthma Prevention & Risk Reduction

Asthma-COPD Overlap (ACO) focuses on a complex condition with features of both asthma and COPD. It highlights challenges in accurate diagnosis using clinical history, spirometry, and biomarkers. The session will emphasize personalized treatment strategies, including inhaled corticosteroids, bronchodilators, and combination therapies to improve patient outcomes. Key discussions will cover risk factors, comorbidities, and exacerbation management. Experts will share evidence-based practices and real-world case studies to enhance clinical decision-making. Attendees will gain practical insights and updated approaches for effective diagnosis, treatment, and long-term management of ACO in diverse healthcare settings.

COPD Pathogenesis focuses on the underlying mechanisms and biological processes involved in the development of Chronic Obstructive Pulmonary Disease (COPD). It will explore the role of chronic inflammation, oxidative stress, genetic susceptibility, and environmental exposures such as tobacco smoke and air pollution. Discussions will highlight cellular and molecular pathways contributing to airway remodeling and lung tissue damage. Experts will also examine disease progression, early pathological changes, and potential therapeutic targets. This session aims to provide a deeper understanding of COPD pathogenesis, enabling the development of more effective prevention strategies and targeted treatments to improve patient outcomes.

Respiratory Infections on the role of respiratory infections in lung health, particularly their impact on conditions such as COPD and asthma. It will cover common bacterial, viral, and fungal infections, including their transmission, diagnosis, and management. Discussions will highlight the link between infections and disease exacerbations, as well as prevention strategies such as vaccination and infection control. Experts will present advances in diagnostic tools, antimicrobial therapies, and emerging treatment approaches. Attendees will gain practical insights into early detection, effective management, and reducing the burden of respiratory infections in clinical practice.

• Bacterial Respiratory Infections
• Advances in Diagnostic Technologies
• Vaccination & Preventive Strategies
• Fungal Lung Infections

Pneumonia & Tuberculosis explores on two major respiratory infections, pneumonia and tuberculosis, highlighting their global impact, diagnosis, and management. It will cover advances in early detection methods, imaging techniques, and laboratory diagnostics, along with current treatment protocols and drug resistance challenges. Discussions will also address risk factors, prevention strategies, and public health approaches, especially in high-burden regions. Experts will share insights on vaccination, antimicrobial therapies, and patient care practices. Attendees will gain practical knowledge to improve clinical outcomes and effectively manage pneumonia and tuberculosis in diverse healthcare settings.

Pulmonary Hypertension, a serious condition characterized by increased pressure in the pulmonary arteries affecting heart and lung function. It will cover advances in early diagnosis, imaging techniques, and hemodynamic assessment. Discussions will highlight underlying causes, disease classification, and risk factors, along with the latest treatment options including targeted therapies and combination approaches. Experts will also address disease progression, patient management, and long-term care strategies. Attendees will gain practical insights into improving diagnosis, optimizing treatment, and enhancing quality of life for patients with pulmonary hypertension.

Lung Fibrosis, a progressive condition characterized by scarring of lung tissue that leads to reduced respiratory function. It will cover the latest insights into disease mechanisms, risk factors, and early diagnostic approaches, including imaging and biomarker analysis. Discussions will highlight advances in antifibrotic therapies, supportive care, and emerging treatment strategies. Experts will also address disease progression, complications, and patient-centered management. Attendees will gain practical knowledge on improving early detection, optimizing treatment plans, and enhancing quality of life for patients with lung fibrosis.

• Pathophysiology of Lung Fibrosis
• Advances in Diagnostic Imaging
• Multidisciplinary & Patient-Centered Care
• Idiopathic Pulmonary Fibrosis (IPF)

Cystic fibrosis, a genetic disorder that affects the lungs and other organs, leading to persistent respiratory infections and reduced lung function. It will cover advances in early diagnosis, genetic screening, and understanding of disease mechanisms. Discussions will highlight innovative therapies, including CFTR modulators, airway clearance techniques, and infection management strategies. Experts will also address multidisciplinary care, nutritional support, and long-term patient management. Attendees will gain valuable insights into improving clinical outcomes, enhancing quality of life, and adopting the latest evidence-based approaches in cystic fibrosis care.

Sleep apnea, a common sleep-related breathing disorder characterized by repeated interruptions in breathing during sleep. It will cover types of sleep apnea, including obstructive and central sleep apnea, along with risk factors and associated complications such as cardiovascular issues. Discussions will highlight advances in diagnostic methods like polysomnography and home sleep testing, as well as treatment options including CPAP therapy, oral appliances, and lifestyle modifications. Experts will also address patient adherence and long-term management strategies. Attendees will gain practical insights into improving diagnosis, treatment, and overall patient outcomes.

Bronchoscopy & Airway Techniques explores bronchoscopy and advanced airway management techniques used in the diagnosis and treatment of respiratory conditions. It will cover flexible and rigid bronchoscopy, endobronchial ultrasound (EBUS), and other minimally invasive procedures for airway evaluation. Discussions will highlight their role in diagnosing lung diseases, tumors, infections, and airway obstructions. Experts will also address therapeutic interventions such as stenting, biopsy, and foreign body removal. Emphasis will be placed on procedural safety, innovation, and clinical best practices. Attendees will gain practical knowledge to enhance diagnostic accuracy and improve patient outcomes in respiratory care.

• Flexible & Rigid Bronchoscopy
• Therapeutic Bronchoscopy
• Safety, Sedation & Clinical Best Practices
• Endobronchial Ultrasound (EBUS) & Advanced Imaging

Interventional Pulmonology, a rapidly evolving field focused on minimally invasive procedures for the diagnosis and treatment of complex lung diseases. It will cover advanced techniques such as endobronchial ultrasound (EBUS), navigational bronchoscopy, airway stenting, and pleural interventions. Discussions will highlight their role in managing lung cancer, airway obstruction, pleural diseases, and other respiratory conditions. Experts will also address procedural safety, patient selection, and emerging technologies. Attendees will gain practical insights into innovative interventions, improving diagnostic precision and enhancing therapeutic outcomes in modern pulmonary care.

Lung Cancer: Diagnosis & Treatment explores the latest advancements in the diagnosis and treatment of lung cancer, one of the leading causes of cancer-related mortality worldwide. It will cover early detection strategies, imaging techniques, and molecular diagnostics that enable accurate staging and personalized treatment planning. Discussions will highlight current treatment approaches, including surgery, chemotherapy, targeted therapy, and immunotherapy. Experts will also address multidisciplinary care, patient management, and emerging innovations in lung cancer research. Attendees will gain valuable insights into improving early diagnosis, optimizing treatment strategies, and enhancing patient outcomes in lung cancer care.

AI in Respiratory Care focuses the transformative role of artificial intelligence in respiratory care, highlighting its impact on diagnosis, treatment, and patient management. It will cover AI-driven tools in imaging analysis, predictive analytics, and early disease detection for conditions such as COPD, asthma, and lung cancer. Discussions will also address machine learning applications in clinical decision support, remote monitoring, and personalized treatment planning. Experts will examine challenges related to data integration, ethics, and implementation in healthcare systems. Attendees will gain insights into how AI is enhancing accuracy, efficiency, and outcomes in modern respiratory medicine.

• AI in Imaging & Diagnostics
• Predictive Analytics & Clinical Decision Support
• Remote Monitoring & Personalized Care
• Data Integration, Ethics & Implementation

Personalized Pulmonary Medicine, focusing on tailored approaches to the prevention, diagnosis, and treatment of respiratory diseases. It will cover the role of genetics, biomarkers, and advanced diagnostics in customizing therapies for conditions such as COPD, asthma, and lung cancer. Discussions will highlight precision medicine strategies, targeted treatments, and patient-specific care plans that improve outcomes and reduce adverse effects. Experts will also address data-driven decision-making and emerging technologies. Attendees will gain valuable insights into delivering individualized care and advancing precision approaches in respiratory healthcare.

COPD Diagnosis & Guidelines explores the latest standards and best practices in the diagnosis and management of Chronic Obstructive Pulmonary Disease (COPD). It will cover updated clinical guidelines, including the use of spirometry, imaging, and symptom assessment tools for accurate diagnosis and staging. Discussions will highlight evidence-based treatment pathways, risk stratification, and management of exacerbations. Experts will also address guideline implementation in clinical practice and challenges in early detection. Attendees will gain practical insights into applying current recommendations to improve diagnosis, optimize treatment strategies, and enhance patient outcomes in COPD care.

Pharmacological management of Chronic Obstructive Pulmonary Disease (COPD), focusing on current and emerging drug therapies. It will cover the use of bronchodilators, inhaled corticosteroids, combination therapies, and novel agents aimed at improving lung function and reducing exacerbations. Discussions will highlight personalized treatment approaches, drug selection based on disease severity, and patient response. Experts will also address medication adherence, side effects, and optimization of inhaler techniques. Attendees will gain practical insights into evidence-based pharmacotherapy strategies to enhance treatment effectiveness and improve quality of life for COPD patients.

• Bronchodilators & Inhaled Therapies
• Personalized Pharmacotherapy in COPD
• Emerging Drugs & Novel Therapeutics
• Adherence, Safety & Inhaler Techniques

Next-Gen COPD Treatments explores emerging and next-generation therapies transforming the management of Chronic Obstructive Pulmonary Disease (COPD). It will cover innovative approaches such as biologics, regenerative medicine, gene-based therapies, and advanced drug delivery systems. Discussions will highlight ongoing clinical trials, novel targets for treatment, and breakthroughs aimed at slowing disease progression and improving patient outcomes. Experts will also address challenges in accessibility, safety, and long-term effectiveness. Attendees will gain insights into future treatment landscapes and cutting-edge innovations that are shaping the next era of COPD care.

Non-Invasive Ventilation (NIV) focuses the role of non-invasive ventilation (NIV) in managing acute and chronic respiratory failure. It will cover key modalities such as CPAP and BiPAP, along with their clinical applications in conditions like COPD exacerbations, sleep apnea, and respiratory distress. Discussions will highlight patient selection, initiation protocols, and monitoring strategies to ensure optimal outcomes. Experts will also address challenges such as patient tolerance, complications, and adherence. Attendees will gain practical insights into effective NIV use, improving respiratory support and enhancing patient care in both hospital and home settings.

Lung transplantation as a life-saving treatment option for patients with end-stage lung diseases. It will cover patient selection criteria, pre-transplant evaluation, and advances in surgical techniques. Discussions will highlight post-transplant care, immunosuppressive therapies, and the management of complications such as rejection and infection. Experts will also address long-term outcomes, ethical considerations, and organ allocation challenges. Attendees will gain valuable insights into improving patient selection, optimizing perioperative care, and enhancing survival and quality of life for lung transplant recipients.

• Patient Selection & Pre-Transplant Evaluation
• Surgical Techniques & Perioperative Management
• Post-Transplant Care & Complication Management
• Long-Term Outcomes, Ethics & Organ Allocation

Pulmonary rehabilitation as a comprehensive, multidisciplinary approach to improving the quality of life for patients with chronic respiratory diseases. It will cover exercise training, breathing techniques, nutritional support, and patient education aimed at enhancing physical capacity and symptom control. Discussions will highlight rehabilitation strategies for COPD, asthma, and post-COVID conditions, along with approaches to improve patient adherence and long-term outcomes. Experts will also address home-based and community rehabilitation programs. Attendees will gain practical insights into designing and implementing effective pulmonary rehabilitation programs for better patient care.

Pediatric Respiratory Care explores respiratory care in infants and children, focusing on the diagnosis and management of common and complex pediatric lung conditions. It will cover disorders such as asthma, bronchiolitis, pneumonia, and congenital lung diseases. Discussions will highlight age-specific diagnostic approaches, treatment strategies, and advances in pediatric respiratory support. Experts will also address preventive care, vaccination, and long-term management to improve child health outcomes. Attendees will gain practical insights into delivering effective, child-centered respiratory care and enhancing clinical practices in pediatric pulmonology.

Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular diseases, highlighting their shared risk factors and clinical impact. It will cover conditions such as hypertension, heart failure, and ischemic heart disease commonly associated with COPD. Discussions will focus on pathophysiological links, early detection, and integrated management strategies. Experts will address the impact of comorbidities on disease progression, treatment outcomes, and patient quality of life. Attendees will gain valuable insights into coordinated care approaches that improve both respiratory and cardiovascular health outcomes.

• Cardiovascular Comorbidities in COPD
• Pathophysiological Links & Shared Risk Factors
• Integrated Diagnosis & Management Strategies
• Impact on Outcomes & Patient-Centered Care

Air Pollution & Tobacco Control focuses the impact of air pollution and tobacco use on respiratory health, with a focus on prevention and control strategies. It will cover the role of environmental pollutants, occupational exposures, and smoking in the development and progression of diseases such as COPD, asthma, and lung cancer. Discussions will highlight public health policies, smoking cessation programs, and global initiatives aimed at reducing exposure and disease burden. Experts will also address awareness, regulatory measures, and community interventions. Attendees will gain practical insights into prevention strategies and policy-driven approaches to improve lung health outcomes.

COPD Prevention & Self-Management explores effective strategies for preventing Chronic Obstructive Pulmonary Disease (COPD) and empowering patients in self-management. It will cover risk reduction approaches such as smoking cessation, minimizing exposure to air pollutants, and early screening for high-risk populations. Discussions will highlight patient education, lifestyle modifications, medication adherence, and the use of digital health tools for monitoring symptoms. Experts will also address action plans for managing exacerbations and improving daily quality of life. Attendees will gain practical insights into promoting prevention and supporting patients in long-term, self-directed COPD care.

• Prevention & Risk Reduction Strategies
• Exacerbation Management & Quality of Life
• Patient Education & Self-Management Practices
• Adherence, Monitoring & Digital Health Tools